Medical/Pharmaceuticals

State Grid Changzhou Power Pioneers Drone-Based Ultraviolet Imaging Technology for Precision Power Line Fault Detection

CHANGZHOU, China, April 29, 2026 /PRNewswire/ -- State Grid Changzhou Power Supply Company has deployed drone-based ultraviolet (UV) imaging technology for the first time to enable precision inspection of distribution lines in Liyang, Changzhou. The new technical solution supports early detection...

2026-04-29 17:04 3814

WHX Bangkok and Medtec Southeast Asia 2026 to Position Thailand as the Gateway to ASEAN's Medical Market

BANGKOK, April 29, 2026 /PRNewswire/ -- From 8 to 10 July, Informa Markets will take the global stage, uniting over 950 exhibitors at International Healthcare Week and reinforcing Thailand's leadership in healthcare and medical manufacturing. The event will feature two major co-located exhibit...

2026-04-29 14:02 4691

ABC Impact Releases 2025 Impact Review

SINGAPORE, April 29, 2026 /PRNewswire/ -- ABC Impact, the Singapore-based Asia-focused impact investment firm, has published its 2025 Impact Review, available atwww.abcimpact.com.sg . The review covers the firm's investment and impact activity across its two funds ov...

2026-04-29 11:00 4113

Alma Unveils Longevity Approach at Alma Academy, Advancing Long-Term Skin Performance

CAESAREA, Israel, April 29, 2026 /PRNewswire/ -- Alma , a Sisram Medical company and a global leader in medical aesthetic solutions, unveiled its longevity strategy at its global Alma Academy, outlining its shift toward a continuous care model and a new long-term growth a...

2026-04-29 09:30 3784

Insilico's Rentosertib Inhalation Solution Receives IND Clearance for the World's First AI-Driven Candidate to Enter Direct-to-Lung Clinical Study

* Following positive Phase IIa results for oral Rentosertib in GENESIS-IPF with good tolerability, a favorable PK profile, and dose-dependent efficacy improvements, the inhalation solution has received IND clearance from the CDE. * The inhalation solution is designed for targeted lung delivery...

2026-04-29 09:00 5059

Alma Unveils Longevity Approach at Alma Academy, Advancing Long-Term Skin Performance

CAESAREA, Israel, April 29, 2026 /PRNewswire/ -- Alma , a Sisram Medical company and a global leader in medical aesthetic solutions, unveiled its longevity strategy at its global Alma Academy, outlining its shift toward a continuous care model and a new long-term growth a...

2026-04-29 08:30 3460

Piramal Pharma Limited Announces Results for Q4 and Full-year FY26

MUMBAI, India, April 28, 2026 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated results for the Fourth Quarter (Q4) and Full-year ended 31st March 2026. Consolidated...

2026-04-29 03:51 4697

ACROBiosystems Wins CiteAb Award, Gaining Worldwide Recognition

SAN DIEGO and NEWARK, Del., April 28, 2026 /PRNewswire/ -- Recently, ACROBiosystems was honored as a "Protein Supplier to Watch in Cancer Research in 2026" at the CiteAb Awards. CiteAb accelerates scientific research by providing a search engine and data services, and its awards leverage high-qu...

2026-04-28 23:00 4445

Natural Field Releases Research Findings on NFTriSolve® Co-Loading Liposome Formula

XI'AN, China, April 28, 2026 /PRNewswire/ -- Natural Field announced that the latest research and development breakthrough of the NFTriSolve® co-loading liposome technology has been achieved. Through a comparison of different formulations and processes in a zebrafish experiment, the research resu...

2026-04-28 22:59 5077

Fosun Pharma Announces Q1 2026 Results: Net Profit Attributable to Shareholders After Deducting Non-Recurring Gains and Losses Increased by 21.96% YoY, With Strong Pipeline Execution

SHANGHAI, April 28, 2026 /PRNewswire/ -- On 28 April, Fosun Pharma ("the Company", stock code: 600196.SH; 02196.HK) announced its results for the first quarter of 2026 (the reporting period). During the reporting period, the Company achieved a total revenue of RMB 10,073 million, representing a ...

2026-04-28 22:54 6859

The Benefits of Prostate Cancer Screening Outweigh the Harms, According to New Patient Guidelines From NCCN

Free, comprehensive guidebook shows how prostate cancer screening has largely deemphasized invasive testing in order to avoid unnecessary procedures and treatment while at the same time saving lives. PLYMOUTH MEETING, Pa., April 28, 2026 /PRNewswire/ -- The National Comprehensive Cancer Network®...

2026-04-28 22:04 4797

ACROBiosystems Showcases AI-Driven Innovation at AACR 2026, Empowering Next-Generation Biologics Discovery

SAN DIEGO and NEWARK, N.J., April 28, 2026 /PRNewswire/ -- From April 17 to 22, 2026, ACROBiosystems—a company dedicated to being a cornerstone of the global biopharmaceutical and healthcare industries—presented its comprehensive, AI‑driven protein solutions at the American Association for Cancer...

2026-04-28 22:00 5353

C-Ray Therapeutics Receives FDA Acceptance of Type II Drug Master File for Copper-64 (Cu-64)

DMF No. 43568 is now active and available for reference in global IND and NDA submissions CHENGDU, China, April 28, 2026 /PRNewswire/ -- C-Ray Therapeutics (Chengdu) Co., Ltd., today announced that its Type II Drug Master File (DMF) for COPPER [64Cu] CHLORIDE FOR RADIOLABELLING has been listed a...

2026-04-28 21:11 3310

Nuevocor Appoints Dr. Monica Shah as Chief Medical Officer

SINGAPORE, PARIS and PHILADELPHIA, April 28, 2026 /PRNewswire/ -- Nuevocor, a clinical-stage biotechnology company developing novel therapies for patients suffering from life-threatening cardiomyopathies, today announced the appointment of Monica Shah, MD, FACC, as Chief Medical Officer. Dr. Shah...

2026-04-28 21:05 4446

World's First Recombinant Botulinum Toxin Type A New Drug Received Marketing Approval in China: a Technological Revolution pioneered by Claruvis Pharmaceutical

CHONGQING, China, April 28, 2026 /PRNewswire/ -- Chongqing Claruvis Pharmaceutical Co., Ltd. recently announced that the China's National Medical Products Administration (NMPA) has approved its Retoxin® (recombinant botulinum toxin type A, project code YY001) for the temporary improvement of mod...

2026-04-28 20:38 4010

Echosens Appoints Romain Baujard as Group Chief Executive Officer

Company to accelerate its mission to make liver health a vital sign in cardiometabolic care; appointment follows retirement of current Group CEO Dominique Legros PARIS, April 28, 2026 /PRNewswire/ -- Echosens , a global diagnostic company specializing in non-invasive m...

2026-04-28 20:00 2797

HoneyNaps Expands into Boston's Kendall Square, Accelerating Global Partnerships in AI Sleep Healthcare

* New office in Boston-Cambridge innovation hub to expand partnerships with healthcare and life sciences leaders * Supported through a Korea Health Industry Development Institute global expansion program * Strategic move expected to accelerate commercialization, clinical collaborations, and...

2026-04-28 19:00 3662

Kuching to Host Malaysia's First CIFA Regional Symposium

KUCHING, Malaysia, April 28, 2026 /PRNewswire/ -- Malaysia has been selected to host the Consortium of Institutes on Family in the Asian Region (CIFA) Regional Symposium 2026, co-organised by the National Coalition for Mental Wellbeing (NCMW) Malaysia and CIFA Hong Kong, with Kuching making histor...

2026-04-28 16:52 4562

Ivonescimab Receives Major Recommendations Across Multiple Therapies in the 2026 CSCO NSCLC Guideline

HONG KONG, April 28, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that ivonescimab, the company's first-in-class PD-1/VEGF bispecific antibody, has secured multiple authoritative updates and upgrades across first-line and later-line settings in the officia...

2026-04-28 16:07 4995

3Shape Receives FDA 510(k) Clearance for 3Shape Dx Software

COPENHAGEN, Denmark, April 28, 2026 /PRNewswire/ -- 3Shape today announced that the U.S. Food and Drug Administration (FDA) has granted FDA clearance for its Dx Software following a review completed on April 10. 2026. The 510(k) Premarket Notification allows Dx (R1) software to be commercially a...

2026-04-28 15:43 3527
1 ... 33343536373839 ... 646